# OnCo record paper-keunchil-park-lancet-2017 (paper). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/key-papers/paper-keunchil-park-lancet-2017/>
  a schema:ScholarlyArticle ;
  onco:kind "paper" ;
  schema:identifier "paper-keunchil-park-lancet-2017" ;
  schema:name "Atezolizumab versus docetaxel in patients with previously treated non-small-cell lung cancer (OAK): a phase 3, open-label, multicentre randomised controlled trial"@en ;
  schema:description "Paper by Keunchil Park indexed on Europe PMC as PubMed record 27979383, in The Lancet (2017), one of the most cited records naming an author with this name at Samsung Medical Center."@en ;
  schema:url <https://onco.cc/key-papers/paper-keunchil-park-lancet-2017/> ;
  schema:dateModified "2026-09-22"^^xsd:date ;
  schema:citation <https://doi.org/10.1016/s0140-6736(16)32517-x>, <https://pubmed.ncbi.nlm.nih.gov/27979383/>, <https://europepmc.org/article/MED/27979383> ;
  onco:tag "europepmc-ingest" ;
  schema:sameAs <https://doi.org/10.1016/s0140-6736(16)32517-x> ;
  schema:datePublished "2017"^^xsd:gYear ;
  schema:author "Rittmeyer A, Barlesi F, Waterkamp D, et al." ;
  onco:people <https://onco.cc/people/keunchil-park/> ;
  onco:journals <https://onco.cc/journals/lancet/> .